"Inking a US ATryn partnership, which could happen at any time."
What makes you suggest that GTCB wants to ink a US ATryn partnership Vs taking the DNDN do-it-alone route? Also, given that ATryn is already approved in the EU and looks even more promising in market share in the US, how come GTCB has not inked such a partnership already? What do you think is the hold-up?
Like you and many others here, I really believe GTCB has an excellent future ahead of it. However, the pps downdrift is worrisome and some other major opportunities are beginning to open up as the market takes a tumble. This could tempt me, and others, to unload our GTCB stock in favor of some other more near-term opportunities that show up in the days ahead. I am not there yet but dead money in an opportunistic market is no fun. It would be a great confidence booster if GTCB could somehow telegraph to its shareholders the possibility of a near-term uplifting event that would stop this needless bleed...
